These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30907134)

  • 21. Retinal stimulation strategies to restore vision: Fundamentals and systems.
    Yue L; Weiland JD; Roska B; Humayun MS
    Prog Retin Eye Res; 2016 Jul; 53():21-47. PubMed ID: 27238218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early and late stage gene therapy interventions for inherited retinal degenerations.
    Botto C; Rucli M; Tekinsoy MD; Pulman J; Sahel JA; Dalkara D
    Prog Retin Eye Res; 2022 Jan; 86():100975. PubMed ID: 34058340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and subcellular optogenetic approaches towards neuroprotection and vision restoration.
    Wood EH; Kreymerman A; Kowal T; Buickians D; Sun Y; Muscat S; Mercola M; Moshfeghi DM; Goldberg JL
    Prog Retin Eye Res; 2023 Sep; 96():101153. PubMed ID: 36503723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable phenotypic expressivity in inbred retinal degeneration mouse lines: A comparative study of C3H/HeOu and FVB/N rd1 mice.
    van Wyk M; Schneider S; Kleinlogel S
    Mol Vis; 2015; 21():811-27. PubMed ID: 26283863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optogenetics for retinal disorders.
    Henriksen BS; Marc RE; Bernstein PS
    J Ophthalmic Vis Res; 2014; 9(3):374-82. PubMed ID: 25667740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ON-bipolar cell gene expression during retinal degeneration: Implications for optogenetic visual restoration.
    Gilhooley MJ; Hickey DG; Lindner M; Palumaa T; Hughes S; Peirson SN; MacLaren RE; Hankins MW
    Exp Eye Res; 2021 Jun; 207():108553. PubMed ID: 33811915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restoration of Vision and Retinal Responses After Adeno-Associated Virus-Mediated Optogenetic Therapy in Blind Dogs.
    Nikonov S; Aravand P; Lyubarsky A; Nikonov R; Luo AJ; Wei Z; Maguire AM; Phelps NT; Shpylchak I; Willett K; Aleman TS; Huckfeldt RM; Ramachandran PS; Bennett J
    Transl Vis Sci Technol; 2022 May; 11(5):24. PubMed ID: 35604672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photochemical approaches to vision restoration.
    Van Gelder RN
    Vision Res; 2015 Jun; 111(Pt B):134-41. PubMed ID: 25680758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging therapies for inherited retinal degeneration.
    Scholl HP; Strauss RW; Singh MS; Dalkara D; Roska B; Picaud S; Sahel JA
    Sci Transl Med; 2016 Dec; 8(368):368rv6. PubMed ID: 27928030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Therapies for Inherited Retinal Diseases-Current Standing, Opportunities and Challenges.
    Vázquez-Domínguez I; Garanto A; Collin RWJ
    Genes (Basel); 2019 Aug; 10(9):. PubMed ID: 31466352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selecting Channelrhodopsin Constructs for Optimal Visual Restoration in Differing Light Conditions.
    Ganjawala TH; Pan ZH
    Methods Mol Biol; 2021; 2191():189-199. PubMed ID: 32865746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapy.
    De Silva SR; Barnard AR; Hughes S; Tam SKE; Martin C; Singh MS; Barnea-Cramer AO; McClements ME; During MJ; Peirson SN; Hankins MW; MacLaren RE
    Proc Natl Acad Sci U S A; 2017 Oct; 114(42):11211-11216. PubMed ID: 28973921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy in inherited retinal degenerative diseases, a review.
    Takahashi VKL; Takiuti JT; Jauregui R; Tsang SH
    Ophthalmic Genet; 2018 Oct; 39(5):560-568. PubMed ID: 30040511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Systematic Review of Optogenetic Vision Restoration: History, Challenges, and New Inventions from Bench to Bedside.
    Stefanov A; Flannery JG
    Cold Spring Harb Perspect Med; 2023 Jun; 13(6):. PubMed ID: 36376079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Losing, preserving, and restoring vision from neurodegeneration in the eye.
    Kerschensteiner D
    Curr Biol; 2023 Oct; 33(19):R1019-R1036. PubMed ID: 37816323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restoring the ON Switch in Blind Retinas: Opto-mGluR6, a Next-Generation, Cell-Tailored Optogenetic Tool.
    van Wyk M; Pielecka-Fortuna J; Löwel S; Kleinlogel S
    PLoS Biol; 2015 May; 13(5):e1002143. PubMed ID: 25950461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview on Research and Clinical Applications of Optogenetics.
    Towne C; Thompson KR
    Curr Protoc Pharmacol; 2016 Dec; 75():11.19.1-11.19.21. PubMed ID: 27960028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Engineering Platform for Clinical Application of Optogenetic Therapy in Retinal Degenerative Diseases.
    Yan B; Nirenberg S
    IEEE J Transl Eng Health Med; 2023; 11():296-305. PubMed ID: 37250684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional interrogation of neural circuits with virally transmitted optogenetic tools.
    De La Crompe B; Coulon P; Diester I
    J Neurosci Methods; 2020 Nov; 345():108905. PubMed ID: 32795553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene therapy of inherited retinal degenerations: prospects and challenges.
    Trapani I; Banfi S; Simonelli F; Surace EM; Auricchio A
    Hum Gene Ther; 2015 Apr; 26(4):193-200. PubMed ID: 25762209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.